XBiotech Inc. (XBIT)
NASDAQ: XBIT · Real-Time Price · USD
2.540
-0.035 (-1.36%)
At close: Apr 28, 2026, 4:00 PM EDT
2.545
+0.005 (0.20%)
After-hours: Apr 28, 2026, 4:10 PM EDT

XBiotech Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Market Capitalization
7773120122107338
Upgrade
Market Cap Growth
-11.80%-39.48%-1.10%13.95%-68.42%-26.11%
Upgrade
Enterprise Value
-48-75-53-80-11399
Upgrade
Last Close Price
2.582.393.954.003.5111.13
Upgrade
PS Ratio
----26.6418.39
Upgrade
PB Ratio
0.560.520.660.560.441.26
Upgrade
P/TBV Ratio
0.550.520.660.560.441.26
Upgrade
P/FCF Ratio
-----5.13
Upgrade
P/OCF Ratio
-----4.87
Upgrade
EV/Sales Ratio
-----5.41
Upgrade
EV/FCF Ratio
-----1.51
Upgrade
Debt / Equity Ratio
--0.06---
Upgrade
Net Debt / Equity Ratio
-0.89-0.89-0.89-0.91-0.90-0.88
Upgrade
Net Debt / EBITDA Ratio
2.332.333.995.596.8210.56
Upgrade
Net Debt / FCF Ratio
3.123.125.0310.4814.11-3.59
Upgrade
Asset Turnover
----0.020.06
Upgrade
Quick Ratio
15.8815.8811.4932.9453.9271.22
Upgrade
Current Ratio
16.0116.0111.5633.0754.0771.49
Upgrade
Return on Equity (ROE)
-28.23%-28.23%-19.21%-10.69%-12.91%-5.63%
Upgrade
Return on Assets (ROA)
-19.93%-19.93%-12.47%-9.92%-8.27%-4.98%
Upgrade
Return on Invested Capital (ROIC)
-322.70%-321.51%-173.66%-179.70%-124.68%-34.91%
Upgrade
Return on Capital Employed (ROCE)
-39.20%-39.20%-23.10%-17.00%-14.20%-9.20%
Upgrade
Earnings Yield
-58.81%-62.50%-32.00%-20.17%-30.79%-5.15%
Upgrade
FCF Yield
-51.92%-55.18%-26.80%-15.68%-14.42%19.48%
Upgrade
Buyback Yield / Dilution
-0.09%-0.09%-0.07%0.00%-1.32%2.53%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.